FDA approves Symbicort to Treat Asthma In Children Ages 6-12

AstraZeneca announced that the US Food and Drug Administration (FDA) approved SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol 80/4.5 micrograms for the treatment of asthma in pediatric patients aged six up to 12 years. … lesen Sie weiter! Quelle: : http://feedproxy.google.com/~r/asthma-allergy/~3/at-JJI6MBAQ/fda-approves-symbicort-to-treat-asthma-in-children-ages-6-12